Preclinical Efficacy and Safety Assessment of an Antibody–Drug Conjugate Targeting the c-RET Proto-Oncogene for Breast CarcinomaMinh Nguyen, Andrew D. Simmons, Toshimitsu Arai et al.|Clinical Cancer Research|2015Cited by 26
TAK-079 is a high affinity monoclonal antibody that effectively mediates CD38+ cell depletionGlennda Smithson, Kathleen Elias, Jonathan Zalevsky et al.|The Journal of Immunology|2017Cited by 14